ÃÅͽÓéÀÖÆ½Ì¨µÇ¼Èë¿Ú

È«²¿
  • È«²¿
  • ²úÎï¹ÜÀí
  • ÐÂÎÅ×ÊѶ
  • ½éÉÜÄÚÈÝ
  • ÆóÒµÍøµã
  • ³£¼ûÎÊÌâ
  • ÆóÒµÊÓÆµ
  • Æóҵͼ²á

ENGLISH

ÃÅͽÓéÀÖÆ½Ì¨µÇ¼Èë¿Ú×ÊѶ

News

ÃÅͽÓéÀÖÆ½Ì¨µÇ¼Èë¿ÚÒ½Ò©ÓëOnconic Therapeutics Inc. Ç©ÊðÒ»¿î¼ØÀë×Ó¾ºÕùÐÔËá×èÖͼÁÊÚȨºÏ×÷ЭÒé


Ðû²¼Ê±¼ä:

2023-03-10

 

¡°2023Äê3ÔÂ10ÈÕ £¬ÃÅͽÓéÀÖÆ½Ì¨µÇ¼Èë¿Ú£¨ÒÔϼò³Æ¡°ÃÅͽÓéÀÖÆ½Ì¨µÇ¼Èë¿ÚÒ½Ò©¡±£© £¬Ó뺫¹úOnconic Therapeutics Inc.£¨ÒÔϼò³Æ¡°Onconic¡±£© £¬Ò»¼ÒרעÓÚÑз¢È«ÇòÁìÏÈÏû»¯µÀÒ©ÎïºÍÏÂÒ»´ú¿¹Ö×ÁöÖÎÁƵÄÉúÎï¼¼Êõ¹«Ë¾ £¬¾ÍOnconic¿ª·¢µÄZastaprzanÇ©ÊðÁËÒ»ÏîÔÚ´óÖлªÇøµÄ¶ÀÕ¼Ðí¿ÉÊÚȨЭÒé¡£¡±
 
ZastaprazanÊÇOnconic×ÔÖ÷Ñз¢µÄÒ»¿î´´Ð¼ØÀë×Ó¾ºÕùÐÔËá×èÖͼÁ£¨P-CAB£© £¬Ä¿Ç°ÕýÔÚº«¹ú¿ªÕ¹Ò»ÏîÕë¶ÔÃÓÀÃÐÔʳ¹ÜÑ׵ĢóÆÚÁÙ´²ÊÔÑé £¬ÏÖÓÐÊý¾Ý±íÃ÷Zastaprazan¾ßÓÐÆðЧ¿ì¡¢ÒÖËáЧ¹û¼ÑÇÒ×÷Óó־ᢲ»Á¼·´Ó³ÉÙµÄÓŵã £¬Î´À´¿ÉÍØÕ¹ÖÁÊ®¶þÖ¸³¦À£Ññ¡¢ÓÄÃÅÂÝÐý¸Ë¾úѬȾºÍ·ÇÃÓÀÃÐÔθʳ¹Ü·´Á÷²¡µÈµÄÖÎÁÆ¡£
 
ÃÅͽÓéÀÖÆ½Ì¨µÇ¼Èë¿ÚÒ½Ò©Ö´Ðж­Ê¼æ×ܲÃÌÆÑô¸ÕÏÈÉúÌåÏÖ£º¡°´Ë´ÎÓëOnconicЯÊÖºÏ×÷ £¬½«³äʵ·¢»Ó¸÷×ÔÓÅÊÆ £¬ÅäºÏÍÆ½øZastaprazan ÔÚ´óÖлªµØÓòµÄ¿ª·¢ºÍÉÌÒµ»¯¡£ÃÅͽÓéÀÖÆ½Ì¨µÇ¼Èë¿ÚÒ½Ò©ÔÚÏû»¯µÀÁìÓòÉî¸û¶àÄê £¬Ò»Ö±ÖÂÁ¦ÓÚÏû»¯µÀ´´ÐÂÒ©µÄ¿ª·¢ £¬´Ë´ÎµÄºÏ×÷½«½øÒ»²½À©³äÃÅͽÓéÀÖÆ½Ì¨µÇ¼Èë¿ÚÒ½Ò©µÄÏû»¯µÀ¹ÜÏß¡£¡±
 
OnconicÊ×ϯִÐйÙJohn Kim²©Ê¿ÌåÏÖ£º¡°ÎÒÃǺÜÐË·ÜÓëÖйú賦µÀÖÎÁÆÁìÓòµÄÁìÏÈÕßÃÅͽÓéÀÖÆ½Ì¨µÇ¼Èë¿ÚÒ½Ò©¸æ¿¢Ð­Òé £¬²¢ÆÚ´ýÃÅͽÓéÀÖÆ½Ì¨µÇ¼Èë¿Úҽҩͨ¹ýÁ½¼Ò¹«Ë¾µÄÃÜÇкÏ×÷ £¬³ÉΪP-CABÊг¡µÄÓ®¼Ò¡£Zastaprazan¾ßÓÐÆðЧ¿ì¡¢Á¬ÐøÊ±¼ä³¤µÄÓŵã £¬Ï£ÍûËüÄܳÉΪÖйúθʳ¹Ü·´Á÷ºÍθËáÏà¹Ø¼²²¡»¼ÕßµÄÖØÒªÖÎÁÆÑ¡Ôñ¡£¡±
 
θʳ¹Ü·´Á÷²¡£¨GERD£©ÊÇÒ»ÖÖ³£¼ûµÄÏû»¯µÀ¼²²¡ £¬ÁÙ´²Ö÷ÒªÌåÏÖΪÉÕÐĺͷ´Ëá¡£ÃÓÀÃÐÔʳ¹ÜÑ×£¨EE£©ÊôÓÚGERDµÄÁìÓò £¬ÓÉÓÚθÄÚÈÝÎï·´Á÷ÖÁʳ¹Ü £¬ÒýÆðʳ¹Ü϶Îð¤Ä¤µÄÃÓÀà £¬ÐγÉEE¡£½üÄêÀ´GERDµÄ·¢²¡ÂʳÊÖðÄêÉÏÉýÇ÷ÊÆ £¬»ùÓÚÈ«ÇòÈËȺµÄ·ÖÎöÿÖÜÖÁÉÙÒ»´Î·ºÆðGERDÖ¢×´µÄ»¼²¡ÂÊΪ13%[1] £¬ ¾Ý±¨µÀÖйúÉçÇøÈËȺGERD»¼²¡ÂÊΪ7.69%[2],ÓÉÓÚÎÒ¹úÈ˿ڻùÊý´ó,»¼²¡ÈËÊýÖÚ¶à £¬ÇÒGERD»¼ÕßÐèÖØ¸´¾ÍÒ½·þÒ© £¬Êг¡¿Õ¼ä¹ãÀ«¡£´«Í³µÄÖÊ×Ó±ÃÒÖÖÆ¼Á£¨PPI£©ÊÇÁÙ´²ÉÏʹÓÃ×îΪ¹ã·ºµÄÒÖËáÒ© £¬IMSÊý¾ÝÏÔʾ2022ÄêÖйú´«Í³PPIsÊг¡¹æÄ£Ô¼Îª127ÒÚÔªÈËÃñ±Ò¡£
 

 

¹ØÓÚOnconic

ͼƬ

Onconic ½¨Á¢ÓÚ2020Äê £¬ÊÇÒ»¼Ò¿ìËÙÉú³¤µÄ¹«Ë¾ £¬×¨×¢ÓÚ賦µÀºÍÖ×ÁöÁìÓò´´ÐÂÒ©(NCEs)µÄÑз¢¡£³ýÁËZastaprazanÍâ £¬Onconic ĿǰÕýÔÚ¿ª·¢ÓÃÓÚÖ×ÁöÖÎÁƵÄÏÂÒ»´úºÏ³ÉÖÂËÀÒ©Îï¡£ÖÂÁ¦ÓÚͨ¹ý´´ÐÂÒ©ÎïÑо¿¸ÄÉÆ¼²²¡»¼ÕߵĽ¡¿µ¡£


²Î¿¼ÎÄÏ×£º
[1]Gastroenterology. 2018 Jan; 154(2): 267¨C276.
[2]Öйú²¿ÃŵØÓò»ùÓÚÉçÇøÈËȺθʳ¹Ü·´Á÷²¡»¼²¡ÂÊMeta·ÖÎö.賦²¡Ñ§ºÍ¸Î²¡Ñ§ÔÓÖ¾ 2020,29(09),1012-1020
ÍøÕ¾µØÍ¼